Study of Venetoclax in Combination With Azacytidine in AML Patients Selected Using Ex Vivo Drug Sensitivity Screening
Clinical trial NCT04267081 · COMPLETED
Trial details
- NCT number
- NCT04267081
- Sponsor
- Helsinki University Central Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-12
- Primary completion
- 2024-02-28
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.